Platelet Function Changes during Neonatal Cardiopulmonary Bypass Surgery: Mechanistic Basis and Lack of Correlation with Excessive Bleeding

Abstract

Thrombocytopenia and platelet dysfunction induced by extracorporeal blood circulation are thought to contribute to postsurgical bleeding complications in neonates undergoing cardiac surgery with cardiopulmonary bypass (CPB). In this study, we examined how changes in platelet function relate to changes in platelet count and to excessive bleeding in neonatal CPB surgery. Platelet counts and platelet P-selectin exposure in response to agonist stimulation were measured at four times before, during, and after CPB surgery in neonates with normal versus excessive levels of postsurgical bleeding. Relative to baseline, platelet counts were reduced in patients while on CPB, as was platelet activation by the thromboxane A2 analog U46619, thrombin receptor activating peptide (TRAP), and collagen-related peptide (CRP). Platelet activation by adenosine diphosphate (ADP) was instead reduced after platelet transfusion. We provide evidence that thrombocytopenia is a likely contributor to CPB-associated defects in platelet responsiveness to U46619 and TRAP, CPB-induced collagen receptor downregulation likely contributes to defective platelet responsiveness to CRP, and platelet transfusion may contribute to defective platelet responses to ADP. Platelet transfusion restored to baseline levels platelet counts and responsiveness to all agonists except ADP but did not prevent excessive bleeding in all patients. We conclude that platelet count and function defects are characteristic of neonatal CPB surgery and that platelet transfusion corrects these defects. However, since CPB-associated coagulopathy is multifactorial, platelet transfusion alone is insufficient to treat bleeding events in all patients. Therefore, platelet transfusion must be combined with treatment of other factors that contribute to the coagulopathy to prevent excessive bleeding.

Keywords

cardiopulmonary bypass - congenital heart disease - neonate - platelets

• References

• 1 Manno CS, Hedberg KW, Kim HC. , et al. Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children. Blood 1991; 77 (05) 930-936
• 2 Petäjä J, Lundström U, Leijala M, Peltola K, Siimes MA. Bleeding and use of blood products after heart operations in infants. J Thorac Cardiovasc Surg 1995; 109 (03) 524-529
• 3 Chambers LA, Cohen DM, Davis JT. Transfusion patterns in pediatric open heart surgery. Transfusion 1996; 36 (02) 150-154
• 4 Williams GD, Bratton SL, Riley EC, Ramamoorthy C. Association between age and blood loss in children undergoing open heart operations. Ann Thorac Surg 1998; 66 (03) 870-875
• 5 Williams GD, Bratton SL, Ramamoorthy C. Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open-heart surgery. Anesth Analg 1999; 89 (01) 57-64
• 6 Moganasundram S, Hunt BJ, Sykes K. , et al. The relationship among thromboelastography, hemostatic variables, and bleeding after cardiopulmonary bypass surgery in children. Anesth Analg 2010; 110 (04) 995-1002
• 7 Unsworth-White MJ, Herriot A, Valencia O. , et al. Resternotomy for bleeding after cardiac operation: a marker for increased morbidity and mortality. Ann Thorac Surg 1995; 59 (03) 664-667
• 8 Guay J, Rivard GE. Mediastinal bleeding after cardiopulmonary bypass in pediatric patients. Ann Thorac Surg 1996; 62 (06) 1955-1960
• 9 Guzzetta NA, Allen NN, Wilson EC, Foster GS, Ehrlich AC, Miller BE. Excessive postoperative bleeding and outcomes in neonates undergoing cardiopulmonary bypass. Anesth Analg 2015; 120 (02) 405-410
• 10 McEwan A. Aspects of bleeding after cardiac surgery in children. Paediatr Anaesth 2007; 17 (12) 1126-1133
• 11 Eaton MP, Iannoli EM. Coagulation considerations for infants and children undergoing cardiopulmonary bypass. Paediatr Anaesth 2011; 21 (01) 31-42
• 12 Arnold PD. Coagulation and the surgical neonate. Paediatr Anaesth 2014; 24 (01) 89-97
• 13 Whiting D, Yuki K, DiNardo JA. Cardiopulmonary bypass in the pediatric population. Best Pract Res Clin Anaesthesiol 2015; 29 (02) 241-256
• 14 Miller BE, Mochizuki T, Levy JH. , et al. Predicting and treating coagulopathies after cardiopulmonary bypass in children. Anesth Analg 1997; 85 (06) 1196-1202
• 15 Straub A, Schiebold D, Wendel HP. , et al. Using reagent-supported thromboelastometry (ROTEM) to monitor haemostatic changes in congenital heart surgery employing deep hypothermic circulatory arrest. Eur J Cardiothorac Surg 2008; 34 (03) 641-647
• 16 Velik-Salchner C, Maier S, Innerhofer P. , et al. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study. Anesth Analg 2009; 108 (06) 1747-1754
• 17 Ranucci M, Carlucci C, Isgrò G, Baryshnikova E. A prospective pilot study of platelet function and its relationship with postoperative bleeding in pediatric cardiac surgery. Minerva Anestesiol 2012; 78 (05) 556-563
• 18 Bønding Andreasen J, Hvas AM, Ravn HB. Marked changes in platelet count and function following pediatric congenital heart surgery. Paediatr Anaesth 2014; 24 (04) 386-392
• 19 Zubair MM, Bailly DK, Lantz G. , et al. Preoperative platelet dysfunction predicts blood product transfusion in children undergoing cardiac surgery. Interact Cardiovasc Thorac Surg 2015; 20 (01) 24-30
• 20 Scott JP, Niebler RA, Stuth EAE. , et al. Rotational thromboelastometry rapidly predicts thrombocytopenia and hypofibrinogenemia during neonatal cardiopulmonary bypass. World J Pediatr Congenit Heart Surg 2018; 9 (04) 424-433
• 21 Maroney SA, Peterson JA, Zwifelhofer W. , et al. Plasma proteolytic cascade activation during neonatal cardiopulmonary bypass surgery. Thromb Haemost 2018; 118 (09) 1545-1555
• 22 Bercovitz RS, Shewmake AC, Newman DK. , et al. Validation of a definition of excessive postoperative bleeding in infants undergoing cardiac surgery with cardiopulmonary bypass. J Thorac Cardiovasc Surg 2018; 155 (05) 2112-2124
• 23 Ji SM, Kim SH, Nam JS. , et al. Predictive value of rotational thromboelastometry during cardiopulmonary bypass for thrombocytopenia and hypofibrinogenemia after weaning of cardiopulmonary bypass. Korean J Anesthesiol 2015; 68 (03) 241-248
• 24 Bull BS, Zucker MB. Changes in platelet volume produced by temperature, metabolic inhibitors, and aggregating agents. Proc Soc Exp Biol Med 1965; 120 (02) 296-301
• 25 Bercovitz RS, Brenner MK, Newman DK. A whole blood model of thrombocytopenia that controls platelet count and hematocrit. Ann Hematol 2016; 95 (11) 1887-1894
• 26 Ferroni P, Speziale G, Ruvolo G. , et al. Platelet activation and cytokine production during hypothermic cardiopulmonary bypass--a possible correlation?. Thromb Haemost 1998; 80 (01) 58-64
• 27 Ichinose F, Uezono S, Muto R. , et al. Platelet hyporeactivity in young infants during cardiopulmonary bypass. Anesth Analg 1999; 88 (02) 258-262
• 28 Guay J, Ruest P, Lortie L. Cardiopulmonary bypass induces significant platelet activation in children undergoing open-heart surgery. Eur J Anaesthesiol 2004; 21 (12) 953-956
• 29 Straub A, Smolich J, d'Udekem Y, Brizard C, Peter K, Horton S. Activation of platelets in young infants during cardiopulmonary bypass. Thromb Haemost 2010; 103 (02) 466-469
• 30 Watson SP, Herbert JM, Pollitt AY. GPVI and CLEC-2 in hemostasis and vascular integrity. J Thromb Haemost 2010; 8 (07) 1456-1467
• 31 Joutsi-Korhonen L, Smethurst PA, Rankin A. , et al. The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression. Blood 2003; 101 (11) 4372-4379
• 32 Trifiro E, Williams SA, Cheli Y. , et al. The low-frequency isoform of platelet glycoprotein VIb attenuates ligand-mediated signal transduction but not receptor expression or ligand binding. Blood 2009; 114 (09) 1893-1899
• 33 Neeves KB, Onasoga AA, Hansen RR. , et al. Sources of variability in platelet accumulation on type 1 fibrillar collagen in microfluidic flow assays. PLoS One 2013; 8 (01) e54680
• 34 Bender M, Hofmann S, Stegner D. , et al. Differentially regulated GPVI ectodomain shedding by multiple platelet-expressed proteinases. Blood 2010; 116 (17) 3347-3355
• 35 Murphy S, Gardner FH. Platelet storage at 22 degrees C; metabolic, morphologic, and functional studies. J Clin Invest 1971; 50 (02) 370-377
• 36 DiMinno G, Silver MJ, Murphy S. Stored human platelets retain full aggregation potential in response to pairs of aggregating agents. Blood 1982; 59 (03) 563-568
• 37 Shapira S, Friedman Z, Shapiro H, Presseizen K, Radnay J, Ellis MH. The effect of storage on the expression of platelet membrane phosphatidylserine and the subsequent impact on the coagulant function of stored platelets. Transfusion 2000; 40 (10) 1257-1263
• 38 Curvers J, van Pampus EC, Feijge MA, Rombout-Sestrienkova E, Giesen PL, Heemskerk JW. Decreased responsiveness and development of activation markers of PLTs stored in plasma. Transfusion 2004; 44 (01) 49-58
• 39 Koessler J, Weber K, Koessler A, Yilmaz P, Boeck M, Kobsar A. Expression and function of purinergic receptors in platelets from apheresis-derived platelet concentrates. Blood Transfus 2016; 14 (06) 545-551
• 40 Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1985; 101 (03) 880-886
• 41 Michelson AD, Frelinger III AL, Furman MI. Current options in platelet function testing. Am J Cardiol 2006; 98 (10A): 4N-10N
• 42 Frelinger III AL, Grace RF, Gerrits AJ. , et al. Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP. Blood 2015; 126 (07) 873-879
• 43 Paul BZ, Jin J, Kunapuli SP. Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors. J Biol Chem 1999; 274 (41) 29108-29114
• 44 Trumel C, Payrastre B, Plantavid M. , et al. A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase. Blood 1999; 94 (12) 4156-4165
• 45 Adam F, Verbeuren TJ, Fauchère JL, Guillin MC, Jandrot-Perrus M. Thrombin-induced platelet PAR4 activation: role of glycoprotein Ib and ADP. J Thromb Haemost 2003; 1 (04) 798-804
• 46 Li Z, Zhang G, Le Breton GC, Gao X, Malik AB, Du X. Two waves of platelet secretion induced by thromboxane A2 receptor and a critical role for phosphoinositide 3-kinases. J Biol Chem 2003; 278 (33) 30725-30731
• 47 Knöfler R, Weissbach G, Kuhlisch E. Critical evaluation of the quantification of ATP release reaction in whole blood. Thromb Res 1996; 84 (03) 157-165
• 48 Knöfler R, Weissbach G, Kuhlisch E. Release of adenosine triphosphate by adenosine diphosphate in whole blood and in erythrocyte suspensions. Am J Hematol 1997; 56 (04) 259-265
• 49 Eisses MJ, Chandler WL. Cardiopulmonary bypass parameters and hemostatic response to cardiopulmonary bypass in infants versus children. J Cardiothorac Vasc Anesth 2008; 22 (01) 53-59
• 50 Hayashi T, Sakurai Y, Fukuda K. , et al. Correlations between global clotting function tests, duration of operation, and postoperative chest tube drainage in pediatric cardiac surgery. Paediatr Anaesth 2011; 21 (08) 865-871
• 51 Krajewski S, Kurz J, Neumann B. , et al. Short-acting P2Y12 blockade to reduce platelet dysfunction and coagulopathy during experimental extracorporeal circulation and hypothermia. Br J Anaesth 2012; 108 (06) 912-921
• 52 Peterson JA, Maroney SA, Zwifelhofer W. , et al. Heparin-protamine balance after neonatal cardiopulmonary bypass surgery. J Thromb Haemost 2018; 16 (10) 1973-1983
• 53 Sola-Visner M. Platelets in the neonatal period: developmental differences in platelet production, function, and hemostasis and the potential impact of therapies. Hematology (Am Soc Hematol Educ Program) 2012; 2012: 506-511
• 54 Margraf A, Nussbaum C, Sperandio M. Ontogeny of platelet function. Blood Adv 2019; 3 (04) 692-703